Recurrent head and neck cancer
Clinical trials for Recurrent head and neck cancer explained in plain language.
Never miss a new study
Get alerted when new Recurrent head and neck cancer trials appear
Sign up with your email to follow new studies for Recurrent head and neck cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine plus immunotherapy shows promise against HPV-Linked head and neck cancer
Disease control OngoingThis trial tests whether adding a vaccine called BNT113 to the immunotherapy drug pembrolizumab works better than pembrolizumab alone for people with advanced head and neck cancer linked to HPV16. About 350 participants will receive either the combination or the standard single d…
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase 2/3 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New trial tests shorter radiation for head and neck cancer that has returned
Disease control PausedThis phase II trial compares two types of radiation for people whose head and neck cancer has come back and cannot be removed with surgery. One method delivers high-dose radiation in fewer sessions, while the other uses standard daily doses over several weeks. The study aims to s…
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New drug combo aims to boost immunotherapy for head and neck cancer
Disease control OngoingThis phase 2 trial tests whether adding ramucirumab to pembrolizumab (Keytruda) works better than pembrolizumab alone for people with PD-L1 positive head and neck cancer that has come back or spread. About 37 participants will receive either the combination or the single drug. Th…
Matched conditions: RECURRENT HEAD AND NECK CANCER
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC